References
1. Mc Aree BJ, O’Donnell ME, Fitzmaurice GJ, et al. Inferior vena cava
thrombosis: a review of current practice. Vasc Med. 2013; 18: 32-43.
2. Agnelli G, Verso M, Ageno W, et al. The MASTER registry on venous
thromboembolism: description of the study cohort. Thromb Res 2008; 121:
605-10.
3. White RH. The epidemiology of venous thromboembolism. Circulation
2003; 107: 14-8.
4. Kahn SR. The post-thrombotic syndrome: the forgotten morbidity of
deep venous thrombosis. J Thromb Thrombolysis 2006; 21: 41-8.
5. Stein PD, Matta F, Yaekoub AY. Incidence of vena cava thrombosis in
the United States. Am J Cardio 2008; 102: 927-9.
6. Kamat GV, Metgud SC, Pattanshetti VM, et al. A cross-sectional study
to detect the prevalence of hyperhomocysteinemia in cases of deep vein
thrombosis. Indian J Surg. 2010;72(4):323-326.
doi:10.1007/s12262-010-0194-1
7. Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of
pretest probability of deep-vein thrombosis in clinical management.
Lancet. 1997; 350; 1795.
8. McAree BJ, O’Donnell ME, Fitzmaurice GJ, et al. Inferior vena cava
thrombosis: a review of current practice. Vasc Med 2013; 18: 32-43.
9. Marcy PY, Magne N, Frenay M, et al. Renal failure secondary to
thrombotic complications of suprarenal inferior vena cava filter in
cancer patients. Cardiovasc Intervent Radiol 2001; 24: 257-
10. Kaufman LB, Yeh BM, Breiman RS, et al. Inferior vena cava filling
defects on CT and MRI. AJR AM J Roentgenol 2005; 185: 717-26.
11. Alkhouli M, Shafi I, Bashir R. Inferior vena cava filter thrombosis
and suprarenal caval stenosis: a double whammy. J Am Coll Cardiol Intv
2015; 8: e23-5
12. Linnemann B, Schmidt H, Scindewolf M, et al. Etiology and VTE risk
factor distribution in patients with inferior vena cava thrombosis.
Thromb Res. 2008; 123: 72-8
1998;338(15):1042-1050. doi:10.1056/NEJM199804093381507
13. Gatt A, Makris M. Hyperhomocysteinemia and venous thrombosis. Semin
Hematol. 2007;44(2):70-76. doi:10.1053/j.seminhematol.2007.01.002
14. Weiss N, Keller C, Hoffmann U, et al. Endothelial dysfunction and
atherothrombosis in mild hyperhomocysteinemia. Vasc Med Lond
Engl. 2002;7(3):227-239. doi:10.1191/1358863x02vm428ra
15. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J
Med.
1998;338(15):1042-1050. doi:10.1056/NEJM199804093381507
16. Gagnier JJ, Kienle G, Altman DG ,et al.The CARE guidelines :
consensus-based clinical case reporting guideline development. Headache
2013:53:1541-1547